123 related articles for article (PubMed ID: 24637229)
1. Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.
Sonabend AM; Carminucci AS; Amendolara B; Bansal M; Leung R; Lei L; Realubit R; Li H; Karan C; Yun J; Showers C; Rothcock R; O J; Califano A; Canoll P; Bruce JN
Neuro Oncol; 2014 Sep; 16(9):1210-9. PubMed ID: 24637229
[TBL] [Abstract][Full Text] [Related]
2. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
[TBL] [Abstract][Full Text] [Related]
3. NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.
Toyoda E; Kagaya S; Cowell IG; Kurosawa A; Kamoshita K; Nishikawa K; Iiizumi S; Koyama H; Austin CA; Adachi N
J Biol Chem; 2008 Aug; 283(35):23711-20. PubMed ID: 18596031
[TBL] [Abstract][Full Text] [Related]
4. Etoposide-induced DNA damage is increased in p53 mutants: identification of ATR and other genes that influence effects of p53 mutations on Top2-induced cytotoxicity.
Menendez D; Anand JR; Murphy CC; Bell WJ; Fu J; Slepushkina N; Buehler E; Martin SE; Lal-Nag M; Nitiss JL; Resnick MA
Oncotarget; 2022; 13():332-346. PubMed ID: 35178190
[TBL] [Abstract][Full Text] [Related]
5. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.
Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M
Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912
[TBL] [Abstract][Full Text] [Related]
6. Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.
Spinazzi EF; Argenziano MG; Upadhyayula PS; Banu MA; Neira JA; Higgins DMO; Wu PB; Pereira B; Mahajan A; Humala N; Al-Dalahmah O; Zhao W; Save AV; Gill BJA; Boyett DM; Marie T; Furnari JL; Sudhakar TD; Stopka SA; Regan MS; Catania V; Good L; Zacharoulis S; Behl M; Petridis P; Jambawalikar S; Mintz A; Lignelli A; Agar NYR; Sims PA; Welch MR; Lassman AB; Iwamoto FM; D'Amico RS; Grinband J; Canoll P; Bruce JN
Lancet Oncol; 2022 Nov; 23(11):1409-1418. PubMed ID: 36243020
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
Khan AB; Lee S; Harmanci AS; Patel R; Latha K; Yang Y; Marisetty A; Lee HK; Heimberger AB; Fuller GN; Deneen B; Rao G
Int J Cancer; 2023 Feb; 152(4):713-724. PubMed ID: 36250346
[TBL] [Abstract][Full Text] [Related]
8. ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes.
Bunch H; Kim D; Naganuma M; Nakagawa R; Cong A; Jeong J; Ehara H; Vu H; Chang JH; Schellenberg MJ; Sekine SI
Nat Commun; 2023 Dec; 14(1):8341. PubMed ID: 38097570
[TBL] [Abstract][Full Text] [Related]
9. Layer-by-Layer Polymer Functionalization Improves Nanoparticle Penetration and Glioblastoma Targeting in the Brain.
Pickering AJ; Lamson NG; Marand MH; Hwang W; Straehla JP; Hammond PT
ACS Nano; 2023 Dec; 17(23):24154-24169. PubMed ID: 37992211
[TBL] [Abstract][Full Text] [Related]
10. ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Shu J; Wang X; Yang X; Zhao G
Sci Rep; 2023 Jan; 13(1):882. PubMed ID: 36650267
[TBL] [Abstract][Full Text] [Related]
11. Design and Characterization of Pressure Monitoring and Insertion system for Intraparenchymal Convection Enhanced Delivery.
Michiels J; Vitale F
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082745
[TBL] [Abstract][Full Text] [Related]
12. Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas.
Müller S; Liu SJ; Di Lullo E; Malatesta M; Pollen AA; Nowakowski TJ; Kohanbash G; Aghi M; Kriegstein AR; Lim DA; Diaz A
Mol Syst Biol; 2016 Nov; 12(11):889. PubMed ID: 27888226
[TBL] [Abstract][Full Text] [Related]
13. Convection-enhanced delivery of immunomodulatory therapy for high-grade glioma.
Sperring CP; Argenziano MG; Savage WM; Teasley DE; Upadhyayula PS; Winans NJ; Canoll P; Bruce JN
Neurooncol Adv; 2023; 5(1):vdad044. PubMed ID: 37215957
[TBL] [Abstract][Full Text] [Related]
14. Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts.
Porath KA; Regan MS; Griffith JI; Jain S; Stopka SA; Burgenske DM; Bakken KK; Carlson BL; Decker PA; Vaubel RA; Dragojevic S; Mladek AC; Connors MA; Hu Z; He L; Kitange GJ; Gupta SK; Feldsien TM; Lefebvre DR; Agar NYR; Eckel-Passow JE; Reilly EB; Elmquist WF; Sarkaria JN
Neurooncol Adv; 2022; 4(1):vdac130. PubMed ID: 36071925
[TBL] [Abstract][Full Text] [Related]
15. Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients.
Gagg H; Williams ST; Conroy S; Myers KN; McGarrity-Cottrell C; Jones C; Helleday T; Rantala J; Rominiyi O; Danson SJ; Collis SJ; Wells G
F1000Res; 2023; 12():954. PubMed ID: 37799492
[TBL] [Abstract][Full Text] [Related]
16. Immune landscape of a genetically engineered murine model of glioma compared with human glioma.
Zamler DB; Shingu T; Kahn LM; Huntoon K; Kassab C; Ott M; Tomczak K; Liu J; Li Y; Lai I; Zorilla-Veloz R; Yee C; Rai K; Kim BY; Watowich SS; Heimberger AB; Draetta GF; Hu J
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35653194
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma remodelling of human neural circuits decreases survival.
Krishna S; Choudhury A; Keough MB; Seo K; Ni L; Kakaizada S; Lee A; Aabedi A; Popova G; Lipkin B; Cao C; Nava Gonzales C; Sudharshan R; Egladyous A; Almeida N; Zhang Y; Molinaro AM; Venkatesh HS; Daniel AGS; Shamardani K; Hyer J; Chang EF; Findlay A; Phillips JJ; Nagarajan S; Raleigh DR; Brang D; Monje M; Hervey-Jumper SL
Nature; 2023 May; 617(7961):599-607. PubMed ID: 37138086
[TBL] [Abstract][Full Text] [Related]
18. TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype
Singh SK; Wang Y; Habib A; Priyadarshini M; Kodavali CV; Chen A; Ma W; Wang J; Hameed NUF; Hu B; Fuller GN; Kulich SM; Amankulor N; Colen RR; Edwards LA; Zinn PO
Front Oncol; 2023; 13():1279806. PubMed ID: 37881491
[TBL] [Abstract][Full Text] [Related]
19. Glioma Induction by Intracerebral Retrovirus Injection.
Verma RK; Lu F; Lu QR
Bio Protoc; 2017 Jul; 7(14):e2404. PubMed ID: 34541135
[TBL] [Abstract][Full Text] [Related]
20. Engineered exosomes targeting MYC reverse the proneural-mesenchymal transition and extend survival of glioblastoma.
Haltom AR; Hassen WE; Hensel J; Kim J; Sugimoto H; Li B; McAndrews KM; Conner MR; Kirtley ML; Luo X; Xie B; Volpert OV; Olalekan S; Maltsev N; Basu A; LeBleu VS; Kalluri R
Extracell Vesicle; 2022 Dec; 1():. PubMed ID: 37503329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
